Handbook on Injectable Drugs - Tapa dura

Sinopsis

This edition of the "Handbook on Injectable Drugs" provides in a concise format monographs containing detailed information on 340 commercially available drugs. Arranged in alphabetical order by non-proprietary name, each monograph provides important information on products (sizes, strengths, volumes, and forms in which the drug is supplied, along with other components of the formulation), dosage and administration, stability, manufacturer and compatibility of the drug with other infusion solutions and drugs. Four types of tables present information on drug solution, drug additive, drug in syringe, and Y-site compatibility. Included in this edition are 22 new monographs: alatrofloxcin mesylate; calcium acetate; dalteparin sodium; dolasetron mesylate; gatifloxacin; hetastarch 6 per cent in lactated electrolyte injection (hextend); itraconazole; linezolid; rocurononium bromide; somatropin; sumatriptan succinate; tirofiban HCL; valproate sodium; alizapride HCL; flecainide acetate; fosfomycin disodium; fotermustine; hyoscine butylbromide; mexiletine HCL; nimodipine; papaveretum; and pentoxiflylline. Ninety per cent of existing monographs from the previous edition have been critically updated or revised. Additionally, there are more than 2500 new test results reported and more than 150 new compatibility studies cited. Up-to-date, comprehensive and easy to use with extensive references, the handbook is ideal for the busy hospital pharmacy.

"Sinopsis" puede pertenecer a otra edición de este libro.